Skip to main content
. 2016 Jul 31;16(3):127–132.

Table 3. Comparative of measurements of quality of life (QLQ BR-23) between groups .

Variables Baseline
(mean ±SD)
After 10 weeks
(mean ±SD)
P value
Components of function
Body image 0.001
Exercise 58.64±27.78 87.3 ±14.85
Control 64.10±25.36 73.39 ±17.93
Sexual function 0.008
Exercise 88.88 ±28.11 80.24 ±31.70
Control 89.10 ±24.90 80.76 ±27.76
Sexual pleasure 0.030
Exercise 83.95 ±35.04 76.54 ±36.76
Control 87.17 ±28.40 76.92 ±29.46
Future prospect‏ 0.001
Exercise 62.50 ±27.80 56.79 ±28.96
Control 26.92 ±23.13 42.30 ±34.71
Total score of functions 0.001
Exercise 65.50 ±6.46 27.16 ±26.61
Control 71.20 ±4.80 78.37 ±10.56
Components of symptoms
Side effect of treatment 0.001
Exercise 41.26 ±20.15 17.63 ±13.12
Control 34.98 ±15.35 25.09 ±14.20
Breast symptoms 0.001
Exercise 25.61 ±18.62 30.70 ±5.55
Control 13.80 ±5.40 24.67 ±13.43
Arm symptoms 0.001
Exercise 42.38 ±23.47 12.12 ±10.69
Control 23.07 ±21.29 25.64 ±17.43
Worry of hair loss 0.001
Exercise 46.91 ±38.40 19.07 ±13.58
Control 41.02 ±35.66 51.00 ±17.50
Total score of symptoms 0.001
Exercise 37.69 ±17.21 17.21 ±12.75
Control 26.49 ±12.18 24.87 ±10.07